Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dan

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 25, 2002
Enzymatic sclerostomy: pilot human studyJacob A Dan, Santosh G Honavar, David A Belyea, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 11, 2023
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
International Journal of Clinical Practice|April 6, 2013
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillationK Huber, S J Connolly, A Kher, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
General Hospital Psychiatry|November 22, 2024
Are opioid use disorder assessments in the emergency department biased? An examination across sex, race, and employment status using item response theoryKatie P Himes, M A Dan Petrovitch, Caroline E Freiermuth, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2026
Cardiovascular pharmacotherapy in year in 2025Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 9, 2025
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Journal of Heart Failure|October 22, 2025
European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to actionMark Luedde, Stefan Agewall, Giuseppe Ambrosio, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 25, 2002
Enzymatic sclerostomy: pilot human studyJacob A Dan, Santosh G Honavar, David A Belyea, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 11, 2023
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
International Journal of Clinical Practice|April 6, 2013
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillationK Huber, S J Connolly, A Kher, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
General Hospital Psychiatry|November 22, 2024
Are opioid use disorder assessments in the emergency department biased? An examination across sex, race, and employment status using item response theoryKatie P Himes, M A Dan Petrovitch, Caroline E Freiermuth, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2026
Cardiovascular pharmacotherapy in year in 2025Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 9, 2025
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Journal of Heart Failure|October 22, 2025
European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to actionMark Luedde, Stefan Agewall, Giuseppe Ambrosio, et al.
Pageof 12